Th1- and Th2-type cytokine expression by activated T lymphocytes from the lung and spleen during the inflammatory response to respiratory syncytial virus

Cytokine

Volumn 12, Issue 6, 2000, Pages 801-807

  Tripp, Ralph A ^a   Moore, Deborah ^a   Anderson, Larry J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Activation; Lymphocytes; Murine; RSV; Th1; Th2

Indexed keywords

CD3 ANTIGEN; DIPEPTIDYL PEPTIDASE IV; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; PHOSPHATIDYLSERINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL LEVEL; CONTROLLED STUDY; CYTOKINE RELEASE; DNA DETERMINATION; FEMALE; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; VIRUS PNEUMONIA;

ANIMALIA; MURINAE; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS; SIGANUS; SYNCYTIAL VIRUS;

EID: 0033921492     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1999.0615     Document Type: Article

References (15)

1. Dudas RA, Karron RA. Respiratory syncytial virus vaccines. Clin Microbiol Rev. 11:1998;430.
2. Dowell SF, Anderson LJ, Gray JE Jr, Erdman DD, Plouffe JF, File TM, Marston BJ, Braimena F. Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. J Infect Dis. 174:1996;456.
3. Graham BS. Pathogenesis of respiratory syncytial virus vaccine-augmented pathology. Am J Resp Crit Care Med. 152:1995;S63.
4. Kim WW, Canchola JG, Brandt CD, Pyles G, Chanock RM, Jensen K, Parrott RH. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemial. 89:1969;422.
5. Groothius JR. Role of antibody and use of respiratory syncytial virus (RSV) immune globulin to prevent severe RSV disease in high-risk children. J Pediatrics. 124:1994;S28.
6. Hall CB, Powell KR, MacDonald NE, Gala CL, Menegus ME, Suffin SC, Cohen HJ. Respiratory syncytial virus infection in children with compromised immune function. New Eng J Med. 315:1986;315.
7. Graham BS, Bunton LA, Rowland J, Wright PF, Karzon DT. Respiratory syncytial virus infection in anti-mu-treated mice. J Virology. 65:1991;4936.
8. Graham BS, Bunton LA, Wright PF, Karzon DT. Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J Clin Invest. 88:1991;1026.
9. Alwan WH, Record FM, Openshaw PJM. CD4+ T cells clear virus but augment disease in mice infected with respiratory syncytial virus. Comparisons with the effects of CD8+ T cells. Clin Exp Immunol. 88:1992;527.
10. Tang YW, Neuzil KM, Fischer JE, Robinson FW, Parker RA, Graham BS. Determinants and kinetics of cytokine expression patterns in lungs of vaccinated mice challenged with respiratory syncytial virus. Vaccine. 15:1997;597.
11. Waris ME, Tsou C, Erdman DD, Zaki SR, Anderson LJ. Respiratory synctial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern. J Virology. 70:1996;2852.
12. Hussell T, Spender LC, Georgiou A, O'Garra A, Openshaw PJH. Th1 and Th2 cytokine induction in pulmonary T cells during infection with respiratory syncytial virus. J Gen Virol. 77:1996;2447.
13. Tripp RA, Hou S, Doherty PC. Temporal loss of the activated L-selectin-low phenotype for virus-specific CD8+ memory T cells. J Immunol. 154:1995;5870.
14. Stark JM, Godding V, Sedgwick JB, Busse WW. Respiratory syncytial virus infection enhances neutrophil and eosinophil adhesion to cultured respiratory epithelial cells. Roles of CD18 and intercellular adhesion molecule-1. J Immunol. 156:1996;4774.
15. Baumgarth N, Egerton M, Kelso A. Activated T cells from draining lymph nodes and effector sites differ in their responses to TCR stimulation. J Immunol. 159:1997;1182.